Do analysts recommend ALP or MEHA?

Portage Biotech currently has a consensus price target of $0.25, suggesting a potential upside of 57.53%. Given Portage Biotech's stronger consensus rating and higher possible upside, equities analysts clearly believe Portage Biotech is more favorable than Functional Brands. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Portage Biotech 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Functional Brands 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is ALP or MEHA more profitable?

Company Net Margins Return on Equity Return on Assets Portage Biotech N/A N/A N/A Functional Brands N/A N/A N/A

Does the media prefer ALP or MEHA?

In the previous week, Portage Biotech had 8 more articles in the media than Functional Brands. MarketBeat recorded 9 mentions for Portage Biotech and 1 mentions for Functional Brands. Portage Biotech's average media sentiment score of 0.96 beat Functional Brands' score of 0.00 indicating that Portage Biotech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Portage Biotech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Functional Brands 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is ALP or PURR more profitable?

Portage Biotech's return on equity of 0.00% beat Hyperliquid Strategies' return on equity. Company Net Margins Return on Equity Return on Assets Portage Biotech N/A N/A N/A Hyperliquid Strategies N/A -56.04% -52.22%

Does the media prefer ALP or PURR?

In the previous week, Portage Biotech had 7 more articles in the media than Hyperliquid Strategies. MarketBeat recorded 9 mentions for Portage Biotech and 2 mentions for Hyperliquid Strategies. Hyperliquid Strategies' average media sentiment score of 1.50 beat Portage Biotech's score of 0.96 indicating that Hyperliquid Strategies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Portage Biotech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hyperliquid Strategies 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to FRMM or ALP?

In the previous week, Forum Markets and Forum Markets both had 9 articles in the media. Portage Biotech's average media sentiment score of 0.96 beat Forum Markets' score of -0.02 indicating that Portage Biotech is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Forum Markets 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Portage Biotech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer ALP or YARW?

In the previous week, Portage Biotech had 5 more articles in the media than Yarrow Bioscience. MarketBeat recorded 9 mentions for Portage Biotech and 4 mentions for Yarrow Bioscience. Portage Biotech's average media sentiment score of 0.96 beat Yarrow Bioscience's score of 0.72 indicating that Portage Biotech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Portage Biotech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Yarrow Bioscience 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer ALP or PSIG?

Portage Biotech presently has a consensus price target of $0.25, indicating a potential upside of 57.53%. Given Portage Biotech's stronger consensus rating and higher possible upside, research analysts plainly believe Portage Biotech is more favorable than PS International Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Portage Biotech 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 PS International Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings and valuation, ALP or PSIG?

PS International Group has higher revenue and earnings than Portage Biotech. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Portage Biotech $100K 37.25 -$38.63M -$8.18 N/A PS International Group $53.15M 0.31 N/A N/A N/A

Is ALP or PSIG more profitable?

Company Net Margins Return on Equity Return on Assets Portage Biotech N/A N/A N/A PS International Group N/A N/A N/A

Does the media prefer ALP or PSIG?

In the previous week, Portage Biotech had 3 more articles in the media than PS International Group. MarketBeat recorded 9 mentions for Portage Biotech and 6 mentions for PS International Group. Portage Biotech's average media sentiment score of 0.96 beat PS International Group's score of 0.77 indicating that Portage Biotech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Portage Biotech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PS International Group 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Portage Biotech (ALP) Competitors

$0.16 -0.01 (-8.48%)

As of 08/17/2026 04:00 PM Eastern

Compare

ALP vs. MEHA, PURR, FRMM, YARW, and PSIG

Should you buy Portage Biotech stock or one of its competitors? Portage Biotech's main competitors and comparable companies include Functional Brands (MEHA), Hyperliquid Strategies (PURR), Forum Markets (FRMM), Yarrow Bioscience (YARW), and PS International Group (PSIG). Companies are selected based on similarities in market, industry, and size.

How does Portage Biotech compare to Functional Brands?

Portage Biotech (NASDAQ:ALP) and Functional Brands (NASDAQ:MEHA) are related small-cap companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, dividends, profitability, earnings, valuation and media sentiment.

In the previous week, Portage Biotech had 8 more articles in the media than Functional Brands. MarketBeat recorded 9 mentions for Portage Biotech and 1 mentions for Functional Brands. Portage Biotech's average media sentiment score of 0.96 beat Functional Brands' score of 0.00 indicating that Portage Biotech is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Portage Biotech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Functional Brands	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Functional Brands has higher revenue and earnings than Portage Biotech. Portage Biotech is trading at a lower price-to-earnings ratio than Functional Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Portage Biotech	$100K	37.25	-$38.63M	-$8.18	N/A
Functional Brands	$6.67M	0.03	$760K	-$0.32	N/A

Company	Net Margins	Return on Equity	Return on Assets
Portage Biotech	N/A	N/A	N/A
Functional Brands	N/A	N/A	N/A

Portage Biotech currently has a consensus price target of $0.25, suggesting a potential upside of 57.53%. Given Portage Biotech's stronger consensus rating and higher possible upside, equities analysts clearly believe Portage Biotech is more favorable than Functional Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Portage Biotech	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Functional Brands	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

13.4% of Portage Biotech shares are owned by institutional investors. 4.3% of Functional Brands shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Portage Biotech beats Functional Brands on 6 of the 11 factors compared between the two stocks.

How does Portage Biotech compare to Hyperliquid Strategies?

Portage Biotech (NASDAQ:ALP) and Hyperliquid Strategies (NASDAQ:PURR) are related small-cap companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, analyst recommendations, risk, institutional ownership and media sentiment.

Portage Biotech's return on equity of 0.00% beat Hyperliquid Strategies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Portage Biotech	N/A	N/A	N/A
Hyperliquid Strategies	N/A	-56.04%	-52.22%

Hyperliquid Strategies has higher revenue and earnings than Portage Biotech. Hyperliquid Strategies is trading at a lower price-to-earnings ratio than Portage Biotech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Portage Biotech	$100K	37.25	-$38.63M	-$8.18	N/A
Hyperliquid Strategies	$1M	1,032.82	-$16.01M	-$7.37	N/A

13.4% of Portage Biotech shares are held by institutional investors. Comparatively, 9.5% of Hyperliquid Strategies shares are held by institutional investors. 8.5% of Hyperliquid Strategies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Portage Biotech currently has a consensus target price of $0.25, suggesting a potential upside of 57.53%. Hyperliquid Strategies has a consensus target price of $12.72, suggesting a potential upside of 77.86%. Given Hyperliquid Strategies' stronger consensus rating and higher possible upside, analysts plainly believe Hyperliquid Strategies is more favorable than Portage Biotech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Portage Biotech	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Hyperliquid Strategies	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Portage Biotech has a beta of 0.61, meaning that its stock price is 39% less volatile than the broader market. Comparatively, Hyperliquid Strategies has a beta of 1.71, meaning that its stock price is 71% more volatile than the broader market.

In the previous week, Portage Biotech had 7 more articles in the media than Hyperliquid Strategies. MarketBeat recorded 9 mentions for Portage Biotech and 2 mentions for Hyperliquid Strategies. Hyperliquid Strategies' average media sentiment score of 1.50 beat Portage Biotech's score of 0.96 indicating that Hyperliquid Strategies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Portage Biotech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hyperliquid Strategies	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Hyperliquid Strategies beats Portage Biotech on 10 of the 15 factors compared between the two stocks.

How does Portage Biotech compare to Forum Markets?

Forum Markets (NASDAQ:FRMM) and Portage Biotech (NASDAQ:ALP) are related small-cap companies, but which is the better stock? We will compare the two companies based on the strength of their risk, profitability, earnings, institutional ownership, analyst recommendations, valuation, dividends and media sentiment.

In the previous week, Forum Markets and Forum Markets both had 9 articles in the media. Portage Biotech's average media sentiment score of 0.96 beat Forum Markets' score of -0.02 indicating that Portage Biotech is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Forum Markets	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Portage Biotech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Forum Markets presently has a consensus price target of $10.00, indicating a potential upside of 69.78%. Portage Biotech has a consensus price target of $0.25, indicating a potential upside of 57.53%. Given Forum Markets' stronger consensus rating and higher probable upside, analysts plainly believe Forum Markets is more favorable than Portage Biotech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Forum Markets	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Portage Biotech	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Forum Markets has a beta of 1.38, suggesting that its stock price is 38% more volatile than the broader market. Comparatively, Portage Biotech has a beta of 0.61, suggesting that its stock price is 39% less volatile than the broader market.

Portage Biotech has a net margin of 0.00% compared to Forum Markets' net margin of -4,971.75%. Portage Biotech's return on equity of 0.00% beat Forum Markets' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Forum Markets	-4,971.75%	-186.48%	-104.41%
Portage Biotech	N/A	N/A	N/A

4.1% of Forum Markets shares are owned by institutional investors. Comparatively, 13.4% of Portage Biotech shares are owned by institutional investors. 25.2% of Forum Markets shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Portage Biotech has lower revenue, but higher earnings than Forum Markets. Forum Markets is trading at a lower price-to-earnings ratio than Portage Biotech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Forum Markets	$6.55M	12.04	-$450.52M	-$33.82	N/A
Portage Biotech	$100K	37.25	-$38.63M	-$8.18	N/A

Summary

Portage Biotech beats Forum Markets on 9 of the 16 factors compared between the two stocks.

How does Portage Biotech compare to Yarrow Bioscience?

Portage Biotech (NASDAQ:ALP) and Yarrow Bioscience (NASDAQ:YARW) are related small-cap companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, profitability, media sentiment, valuation and institutional ownership.

Portage Biotech presently has a consensus target price of $0.25, suggesting a potential upside of 57.53%. Yarrow Bioscience has a consensus target price of $58.00, suggesting a potential upside of 40.10%. Given Portage Biotech's higher probable upside, research analysts clearly believe Portage Biotech is more favorable than Yarrow Bioscience.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Portage Biotech	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Yarrow Bioscience	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

In the previous week, Portage Biotech had 5 more articles in the media than Yarrow Bioscience. MarketBeat recorded 9 mentions for Portage Biotech and 4 mentions for Yarrow Bioscience. Portage Biotech's average media sentiment score of 0.96 beat Yarrow Bioscience's score of 0.72 indicating that Portage Biotech is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Portage Biotech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Yarrow Bioscience	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Yarrow Bioscience has higher revenue and earnings than Portage Biotech. Yarrow Bioscience is trading at a lower price-to-earnings ratio than Portage Biotech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Portage Biotech	$100K	37.25	-$38.63M	-$8.18	N/A
Yarrow Bioscience	$570K	48.66	-$26.48M	-$19.00	N/A

Portage Biotech has a beta of 0.61, suggesting that its stock price is 39% less volatile than the broader market. Comparatively, Yarrow Bioscience has a beta of 1.95, suggesting that its stock price is 95% more volatile than the broader market.

Portage Biotech has a net margin of 0.00% compared to Yarrow Bioscience's net margin of -4,726.21%. Portage Biotech's return on equity of 0.00% beat Yarrow Bioscience's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Portage Biotech	N/A	N/A	N/A
Yarrow Bioscience	-4,726.21%	-84.40%	-77.68%

13.4% of Portage Biotech shares are owned by institutional investors. Comparatively, 83.8% of Yarrow Bioscience shares are owned by institutional investors. 3.0% of Yarrow Bioscience shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Yarrow Bioscience beats Portage Biotech on 8 of the 15 factors compared between the two stocks.

How does Portage Biotech compare to PS International Group?

Portage Biotech (NASDAQ:ALP) and PS International Group (NASDAQ:PSIG) are related small-cap companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment and valuation.

Company	Net Margins	Return on Equity	Return on Assets
Portage Biotech	N/A	N/A	N/A
PS International Group	N/A	N/A	N/A

PS International Group has higher revenue and earnings than Portage Biotech.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Portage Biotech	$100K	37.25	-$38.63M	-$8.18	N/A
PS International Group	$53.15M	0.31	N/A	N/A	N/A

13.4% of Portage Biotech shares are owned by institutional investors. Comparatively, 29.7% of PS International Group shares are owned by institutional investors. 68.9% of PS International Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Portage Biotech presently has a consensus price target of $0.25, indicating a potential upside of 57.53%. Given Portage Biotech's stronger consensus rating and higher possible upside, research analysts plainly believe Portage Biotech is more favorable than PS International Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Portage Biotech	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
PS International Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Portage Biotech had 3 more articles in the media than PS International Group. MarketBeat recorded 9 mentions for Portage Biotech and 6 mentions for PS International Group. Portage Biotech's average media sentiment score of 0.96 beat PS International Group's score of 0.77 indicating that Portage Biotech is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Portage Biotech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PS International Group	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Portage Biotech has a beta of 0.61, suggesting that its share price is 39% less volatile than the broader market. Comparatively, PS International Group has a beta of 0.07, suggesting that its share price is 93% less volatile than the broader market.

Summary

Portage Biotech beats PS International Group on 6 of the 9 factors compared between the two stocks.

Get Portage Biotech News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ALP vs. The Competition

Export

Metric	Portage Biotech	IT Services Industry	Technology Sector	NASDAQ Exchange
Market Cap	$4.07M	$11.36B	$30.57B	$13.06B
Dividend Yield	N/A	2.82%	2.72%	10.62%
P/E Ratio	-0.02	13.69	75.32	25.39
Price / Sales	37.25	64.28	598.15	70.90
Price / Cash	N/A	44.39	53.35	38.47
Price / Book	0.57	8.41	8.36	6.51
Net Income	-$38.63M	$269.32M	$679.85M	$347.22M
7 Day Performance	-16.91%	0.62%	0.96%	1.27%
1 Month Performance	-52.20%	5.43%	4.66%	2.72%
1 Year Performance	N/A	32.82%	200.13%	21.85%

Portage Biotech Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ALP Portage Biotech	2.824 of 5 stars	$0.16 -8.5%	$0.25 +57.5%	N/A	$4.07M	$100K	N/A	6	News Coverage Analyst Forecast Short Interest Decrease Analyst Revision Gap Down
MEHA Functional Brands	0.028 of 5 stars	$0.00 +7.3%	N/A	N/A	$188K	$6.67M	N/A	33	News Coverage Gap Down
PURR Hyperliquid Strategies	2.3498 of 5 stars	$6.82 +0.1%	$12.72 +86.5%	N/A	$983.69M	$1M	N/A	N/A	Positive News Gap Up
FRMM Forum Markets	2.771 of 5 stars	$6.23 +6.7%	$10.00 +60.5%	N/A	$78.20M	$6.55M	N/A	7	Earnings Report Analyst Revision Gap Down
YARW Yarrow Bioscience	3.2919 of 5 stars	$37.70 -0.7%	$58.00 +53.8%	N/A	$25.34M	$570K	N/A	30	Earnings Report

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ALP) was last updated on 8/18/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Portage Biotech (ALP) Competitors

ALP vs. MEHA, PURR, FRMM, YARW, and PSIG

How does Portage Biotech compare to Functional Brands?

Summary

How does Portage Biotech compare to Hyperliquid Strategies?

Summary

How does Portage Biotech compare to Forum Markets?

Summary

How does Portage Biotech compare to Yarrow Bioscience?

Summary

How does Portage Biotech compare to PS International Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALP vs. The Competition

Portage Biotech Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Portage Biotech (ALP) Competitors

ALP vs. MEHA, PURR, FRMM, YARW, and PSIG

How does Portage Biotech compare to Functional Brands?

Does the media prefer ALP or MEHA?

Which has better valuation and earnings, ALP or MEHA?

Is ALP or MEHA more profitable?

Do analysts recommend ALP or MEHA?

Do insiders & institutionals have more ownership in ALP or MEHA?

Summary

How does Portage Biotech compare to Hyperliquid Strategies?

Is ALP or PURR more profitable?

Which has higher earnings & valuation, ALP or PURR?

Do institutionals & insiders hold more shares of ALP or PURR?

Do analysts rate ALP or PURR?

Which has more risk & volatility, ALP or PURR?

Does the media prefer ALP or PURR?

Summary

How does Portage Biotech compare to Forum Markets?

Does the media refer more to FRMM or ALP?

Do analysts rate FRMM or ALP?

Which has more volatility & risk, FRMM or ALP?

Is FRMM or ALP more profitable?

Do insiders & institutionals believe in FRMM or ALP?

Which has better earnings and valuation, FRMM or ALP?

Summary

How does Portage Biotech compare to Yarrow Bioscience?

Do analysts rate ALP or YARW?

Does the media prefer ALP or YARW?

Which has higher valuation & earnings, ALP or YARW?

Which has more volatility and risk, ALP or YARW?

Is ALP or YARW more profitable?

Do institutionals & insiders hold more shares of ALP or YARW?

Summary

How does Portage Biotech compare to PS International Group?

Is ALP or PSIG more profitable?

Which has preferable earnings and valuation, ALP or PSIG?

Do institutionals and insiders believe in ALP or PSIG?

Do analysts prefer ALP or PSIG?

Does the media prefer ALP or PSIG?

Which has more risk & volatility, ALP or PSIG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALP vs. The Competition

Portage Biotech Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools